First Time Loading...
M

Mayinglong Pharmaceutical Group Co Ltd
SSE:600993

Watchlist Manager
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Watchlist
Price: 27.84 CNY 2.5% Market Closed
Updated: May 4, 2024

Mayinglong Pharmaceutical Group Co Ltd
Income to Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mayinglong Pharmaceutical Group Co Ltd
Income to Minority Interest Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors

Company Income to Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
M
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Income to Minority Interest
-¥14m
CAGR 3-Years
-94%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Income to Minority Interest
-¥69.6m
CAGR 3-Years
-42%
CAGR 5-Years
N/A
CAGR 10-Years
-34%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Income to Minority Interest
¥36.6m
CAGR 3-Years
32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Income to Minority Interest
-¥28.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Income to Minority Interest
¥239.7k
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Mayinglong Pharmaceutical Group Co Ltd's Income to Minority Interest?
Income to Minority Interest
-14m CNY

Based on the financial report for Sep 30, 2023, Mayinglong Pharmaceutical Group Co Ltd's Income to Minority Interest amounts to -14m CNY.

What is Mayinglong Pharmaceutical Group Co Ltd's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 3Y
-94%

Over the last year, the Income to Minority Interest growth was -1 854%. The average annual Income to Minority Interest growth rates for Mayinglong Pharmaceutical Group Co Ltd have been -94% over the past three years .